Market Overview:
The global acute ischemic stroke diagnosis and treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of stroke, rising awareness about early diagnosis and treatment of stroke, and technological advancements in the field of diagnostic and therapeutic procedures for stroke. The global acute ischemic stroke diagnosis and treatment market can be segmented on the basis of type of diagnostic procedure, application, and region. On the basis of type of diagnostic procedure, the market can be divided into computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and others. The CT segment is expected to account for a major share in terms of revenue in 2018 owing to its high usage for diagnosing various types of strokes.
Product Definition:
The definition of an acute ischemic stroke is a stroke that occurs suddenly as a result of a blockage in one of the blood vessels supplying blood to the brain. Acute ischemic strokes are serious and require immediate medical attention. The importance of an accurate diagnosis and timely treatment cannot be overstated, as the consequences of an untreated or unsuccessfully treated acute ischemic stroke can be devastating.
Computed Tomography (CT):
Computed tomography is a diagnostic medical procedure that utilizes X-rays to obtain detailed information about the internal structure of patients. In this procedure, a computer controls the X-ray source, detector and monitor. The data obtained from the scan is then processed by an algorithm which gives out accurate results.
The CT market was valued at USD 3,349 million in 2015.
Magnetic Resonance Imaging (MRI):
Magnetic resonance imaging (MRI) is a diagnostic procedure that uses magnetic fields and radio waves to produce images of body tissues. MRI works by causing hydrogen nuclei to align in the direction of the magnetic field, which produces an image when the signal received is analyzed. MRI scanners are devices used for scanning bodies for diagnosing medical conditions such as tumors, infections, & other diseases.
Application Insights:
Based on application, the global acute ischemic stroke diagnosis and treatment market are segmented into hospital-based, specialty clinics, and others. Hospital-based segment held the largest share in 2017 owing to factors such as availability of advanced healthcare facilities with experienced staff in case of emergencies along with a high index of suspicion required for diagnosing AIS.
The specialty clinics segment is expected to grow at a lucrative rate over the forecast period due to increasing number of patients seeking out second opinions regarding their conditions after being diagnosed by primary care physicians or neurologists at hospitals. Furthermore, rising awareness about timely treatment among both patients as well as healthcare professionals will boost growth further. However, this may increase costs associated with diagnostics tests and medication which could lead to higher prices for consumers; however these increases would be nominal when compared to overall market growth rates during the same period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable healthcare infrastructure, high adoption of advanced technologies, and presence of key players in this region. Moreover, increasing prevalence of stroke disorders is also expected to contribute toward regional growth over the forecast period. For instance, according to a study published by American Heart Association (AHA), stroke is the fifth leading cause of death among U.S citizens accounting for around 730,000 deaths every year.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India.
Growth Factors:
- Increasing incidence of stroke: The incidence of stroke is increasing globally due to the aging population and rising rates of obesity, hypertension, and diabetes. This is expected to drive the demand for acute ischemic stroke diagnosis and treatment products.
- Growing awareness about strokes: There is a growing awareness among people about strokes and their symptoms. This has led to an increase in the number of people seeking timely treatment for strokes, which is driving the growth of the market for acute ischemic stroke diagnosis and treatment products.
- Technological advancements in diagnostic tools: There have been significant advancements in diagnostic tools for acute ischemic stroke over the past few years. These advances are helping healthcare professionals diagnose strokes more accurately and quickly, which is driving market growth.
- Rising demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due to their lower risk profile as compared to traditional surgical procedures. This is leading more patients to opt for minimally invasive treatments for acute ischemic stroke, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Ischemic Stroke Diagnosis and Treatment Market Research Report
By Type
Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others
By Application
Hospital, Specialty Clinic, Others
By Companies
Abbott, Medtronic, Boston Scientific, Cordis, Philips, GE Healthcare, Siemens, Stryker, Genentech, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Acute Ischemic Stroke Diagnosis and Treatment Market Report Segments:
The global Acute Ischemic Stroke Diagnosis and Treatment market is segmented on the basis of:
Types
Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialty Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Medtronic
- Boston Scientific
- Cordis
- Philips
- GE Healthcare
- Siemens
- Stryker
- Genentech
- Merck
Highlights of The Acute Ischemic Stroke Diagnosis and Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
- By Application:
- Hospital
- Specialty Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Ischemic Stroke Diagnosis and Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acute ischemic stroke is a medical emergency that can occur when blood flow to the brain is blocked. If not treated quickly, the condition can lead to permanent damage or death. The first step in diagnosing acute ischemic stroke is ruling out other possible causes of symptoms, such as a head injury or an infection. Doctors then use a variety of tests to determine how much blood flow has been lost and whether there are any blockages in the arteries leading to the brain. If necessary, they may perform surgery to remove blockages from arteries or place stents into them to help restore blood flow.
Some of the major companies in the acute ischemic stroke diagnosis and treatment market are Abbott, Medtronic, Boston Scientific, Cordis, Philips, GE Healthcare, Siemens, Stryker, Genentech, Merck.
The acute ischemic stroke diagnosis and treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Ischemic Stroke Diagnosis and Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Ischemic Stroke Diagnosis and Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Ischemic Stroke Diagnosis and Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size & Forecast, 2020-2028
4.5.1 Acute Ischemic Stroke Diagnosis and Treatment Market Size and Y-o-Y Growth
4.5.2 Acute Ischemic Stroke Diagnosis and Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Computed Tomography (CT)
5.2.2 Magnetic Resonance Imaging (MRI)
5.2.3 Carotid Ultrasound
5.2.4 Cerebral Angiography
5.2.5 Electrocardiography
5.2.6 Echocardiography
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Ischemic Stroke Diagnosis and Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Ischemic Stroke Diagnosis and Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Computed Tomography (CT)
9.6.2 Magnetic Resonance Imaging (MRI)
9.6.3 Carotid Ultrasound
9.6.4 Cerebral Angiography
9.6.5 Electrocardiography
9.6.6 Echocardiography
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialty Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Computed Tomography (CT)
10.6.2 Magnetic Resonance Imaging (MRI)
10.6.3 Carotid Ultrasound
10.6.4 Cerebral Angiography
10.6.5 Electrocardiography
10.6.6 Echocardiography
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialty Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Computed Tomography (CT)
11.6.2 Magnetic Resonance Imaging (MRI)
11.6.3 Carotid Ultrasound
11.6.4 Cerebral Angiography
11.6.5 Electrocardiography
11.6.6 Echocardiography
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialty Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Computed Tomography (CT)
12.6.2 Magnetic Resonance Imaging (MRI)
12.6.3 Carotid Ultrasound
12.6.4 Cerebral Angiography
12.6.5 Electrocardiography
12.6.6 Echocardiography
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialty Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Computed Tomography (CT)
13.6.2 Magnetic Resonance Imaging (MRI)
13.6.3 Carotid Ultrasound
13.6.4 Cerebral Angiography
13.6.5 Electrocardiography
13.6.6 Echocardiography
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialty Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Ischemic Stroke Diagnosis and Treatment Market: Competitive Dashboard
14.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Medtronic
14.3.3 Boston Scientific
14.3.4 Cordis
14.3.5 Philips
14.3.6 GE Healthcare
14.3.7 Siemens
14.3.8 Stryker
14.3.9 Genentech
14.3.10 Merck
